Shamik Bhattacharyya, MD, the associate professor of neurology at Harvard Medical School, discussed a study presented at ECTRIMS 2024 that compared the effectiveness and safety profiles of FDA-approved NMOSD therapies with other commonly used treatments. Read More: https://www.neurologylive.com/view/co...